- Daniel Gibson, Anthony Nolan’s Assistant Director of the Cell and Gene Therapy Service, talks about the importance of where starting materials come from and how the Anthony Nolan…
- The new drug delivery system is made up of three parts: An anti-cancer drug – The scientists use antibodies that target a protein called PD-1 (programmed cell death…
- In this blog, some of our patients talk about how post-transplant complications with their eyes, including graft vs host disease (GvHD), have impacted their daily lives and…
- Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best…
- Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one…
- After the news that the Scottish Medicine Consortium has recommended letermovir (Prevymis) for routine use on the NHS in Scotland, Bradley from our Policy and Public Affairs team…
- In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched…
- When our charity began back in 1974, we relied on basic borrowed lab equipment to add donors to our register and stored their tissue type records in shoe boxes. Since these humble…
- In our latest blog, Science Communications Manager Dr Jonathan Kay, looks at a recent publication from researchers at the Anthony Nolan Cell Therapy Centre in Nottingham. It…
Reducing the risk of infection from cosmetic products and toiletries after your stem cell transplant
In this blog, our Science Communications Manager, Jonathan Kay, looks at how make-up products could cause infections post-transplant and the steps you can take to help reduce the…